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Pursuing the middleman: the hunt for integrins
 
y the mid-1970s, the idea of a
transmembrane molecule linking
the cytoskeleton to the extracellular
matrix (ECM) had some supporting evi-
dence. Adhesion molecules were hot in
areas ranging from developmental biology
to tumor biology, and the mounting sugges-
tive evidence that a “fibronectin receptor”
existed made it a “Holy Grail” for the next
decade, recalls Richard Hynes, discoverer
of fibronectin, in a memoir (Hynes, 2004).
 
Go monoclonal
 
Alan “Rick” Horwitz, then at the Univer-
sity of Pennsylvania in Philadelphia, had
joined the gaggle of labs using antibodies
to look for important cell adhesion players.
But he was intimidated by the tedious,
iterative method of the day in which
labs generated polyclonal antibodies to
cell surface molecules, screened them
for the ability to disrupt adhesion, and
then tried to narrow down antigens by
successive purification and new antibody
generation.
B
An anti-integrin antibody (bottom) makes 
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Not only did the approach require too
many resources for a relatively small lab,
but Horwitz noted that some labs (including
that of Clayton Buck at the Wistar Institute
on the same campus) ran into dead-ends
with the messy system, never reaching one
clear antigen target molecule. When a
colleague teaching with Horwitz told him
of the new technique using hybridomas to
generate monoclonal antibodies, “it was
just obvious that it was the way to get these
molecules, to get an adhesion-blocking
antibody that was pure.”
So his lab set to work immunizing
mice with cell surface blebs of chick
myoblasts. The resulting hybridoma super-
natants  were assayed for, among other
things, their ability to detach myoblasts
from the plastic culture dish. Horwitz
recalls that a technician mistakenly
thought one antibody was killing off the
cells because they were rounding up and
floating to the medium surface in such
hoards. A quick investigation revealed
that the detached myoblasts were alive
and well and still able to fuse with each
other in character with normal developing
muscle cells. The antibody also released
cells from an explant of chick embryo
muscle, giving it in vivo significance.
That antibody eventually became known
as the cell substrate attachment antibody,
or CSAT.
 
Antibody to antigen to clone
 
Knowing the Buck lab would be extremely
interested and that it would speed the
study along, Horwitz walked over to
broker a collaboration. The study became
one of the first to use a monoclonal anti-
body to disrupt a complex cellular process
like adhesion and would eventually lead
all the way to identification of the antigen
molecule (Neff et al., 1982). But it wasn’t
until he saw the clean immunofluorescence
of CSAT, reminiscent of adhesion plaque
staining, that Horwitz realized CSAT’s
antigen was in fact a candidate for the
transmembrane linker connecting actin
to fibronectin (Neff et al., 1982).
This notion was strengthened by
Caroline Damsky in the Buck lab, and by
Wen-Tien Chen, at Georgetown Univer-
sity in Washington, DC, and Ken Yamada
at the NIH. Chen and Yamada had been
characterizing a similar cell-detaching
monoclonal antibody, JG22, that they had
obtained from another lab (Greve and
Gottlieb, 1982). Both groups showed by
immunofluorescence that their antigens
lined up with fibronectin and actin (Chen
et al., 1985; Damsky et al., 1985).
Richard Hynes got to see this “beau-
tiful immunofluorescence,” in this case
generated by the CSAT antibody, during
seminar visits in 1984. He was convinced
that the CSAT antigen was the fibronectin
receptor and was keen to collaborate since
his group at the Massachusetts Institute of
Technology (Cambridge, MA) was well-
poised with an expression cloning system.
They used the highly specific antibodies to
clone the cDNA encoding the receptor,
leading to the Buck-Horwitz-Hynes publi-
cation of the sequence of the 
 
 
 
1 subunit of
“integrin,” the name finally coined by
Hynes (Tamkun et al., 1986).
 
Binding proof
 
While the cloning was ongoing, direct
binding between the CSAT antigen and
fibronectin still had to be demonstrated.
When Horwitz heard Yamada present his
data on the low affinity of fibronectin for
cells, he realized the ligand was probably
falling off during column washing. He
switched to a gel filtration strategy using
buffer equilibrated with fibronectin so that
the CSAT antigen always saw its ligand.
Under these saturating conditions, the two
molecules ran off the column bound to-
gether as a complex (Horwitz et al., 1985),
a result confirmed independently by the
Yamada lab (Akiyama et al., 1986). He and
Buck used the same method to show that
the antigen acted as a laminin receptor, and
delivered a “home-run” by establishing the
transmembrane link in vitro, with integrin
binding both to the ECM fibronectin and to
cytoplasmic talin (Horwitz et al., 1986).
During this time, Michael Piersch-
bacher working with Erkki Ruoslahti and
the Yamada lab showed that peptides
containing the sequence RGD comprised
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the recognition motif in fibronectin.
Pierschbacher and Ruoslahti used this
finding to isolate the fibronectin receptor
using a modified affinity–column approach
(Pytela et al., 1985).
Much work would come later, defin-
ing the roles of all of the ECM components,
cytoskeletal players (Otey et al., 1990), and
integrin subunits (e.g., Wayner and Carter,
1987), including those acting in lymphocyte
adhesion (Jalakanen et al., 1987; Dustin and
Springer, 1988; Diamond et al., 1990). But
Buck notes that out of the 1982 CSAT
paper “came definitive identification of the
integrins as a complex linking the cyto-
skeleton to the ECM. It also led to the
sequencing of the 
 
 
 
1 subunit, and the field
developed rapidly after that.”
The search also integrated the Buck,
Horwitz, Hynes, and Yamada laboratories
into lasting friendships and collaborations.
 
Frog egg extracts can do a cell’s work
 
or his graduate project at the University of Toronto,
Manfred Lohka wanted to answer one simple question:
what enzyme was controlling the decondensation of
a sperm nucleus when it entered the egg
 
?
 
 At the time, an
egg protease was thought to be involved, so he figured he
should start by making egg extracts in which to test sperm.
He got much more than he bargained for, including the
birth of a potent cell-free biochemical assay.
After harvesting a test tube of eggs from 
 
Rana pipiens
 
frogs, Lohka could spin the eggs at low speed and pop the
cytoplasmic contents out of their plasma membranes “just
like taking the skin off a grape.” If he added 
 
Xenopus laevis
 
sperm heads to the activated cytoplasm, he observed that
the sperm heads transformed into pronuclei and then mitotic
chromosomes (Lohka and Masui, 1983).
But it wasn’t until Lohka and advisor Yoshio Masui
looked at their extract-plus-sperm preparations by electron
microscopy that they realized that not only did the sperm
nucleus decondense, but a nuclear envelope was assem-
bling around it as well (Lohka and Masui, 1984). Lohka
provided one of the first descriptions of envelope assembly:
membrane vesicles flattened and fused into a double-mem-
braned structure, complete with nuclear pores. In addition,
if Lohka fractionated the egg extracts with a higher spin
and separated them into soluble and particulate fractions,
he could show that envelope assembly required both.
Lohka credits Masui’s love of unorthodox approaches
for the discovery that egg cytoplasm can support cellular
F
 
“We believed in what we did,” Horwitz re-
calls. “We first had a handle on adhesion,
and then neuronal outgrowth and cancer
came into view. At one point, we thought we
had the whole world.” The field would go on
to show that this receptor was part of a larger
cell biology story—initiating cell signaling
events central to many cell activities. 
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activities at least for short peri-
ods. “That was back when how
you did experiments was an
expression of your personality,”
says Lohka, now at the Univer-
sity of Calgary in Canada.
He notes that the study
outcomes were not as important
in the long run “as the notion
that you could actually get quite
Frog egg extracts allow 
the study of nuclear enve-
lope formation.
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complex cell processes to occur
in cell-free extracts.” The system was used to purify
metaphase-promoting factor (Lohka et al., 1988), which led
to the identification of cdc2 and cyclin as its components
(Gautier et al., 1990) and the extracts became a valuable
tool for further investigating the cell cycle (Murray, 1991). The
system has also been used to study nuclear transport (New-
meyer et al., 1986), DNA replication (Mills et al., 1989), and
spindle microtubule dynamics (Heald et al., 1996). 
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